A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study

被引:211
作者
Goto, Masashi [1 ]
Wakai, Kenji [2 ]
Kawamura, Takashi [1 ]
Ando, Masahiko [1 ]
Endoh, Masayuki [3 ]
Tomino, Yasuhiko [4 ]
机构
[1] Kyoto Univ, Hlth Serv, Kyoto, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Prevent Med Biostat & Med Decis Making, Nagoya, Aichi 4648601, Japan
[3] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan
[4] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan
关键词
cohort studies; IgA nephropathy; prognosis; renal dialysis; risk factors; ANGIOTENSIN-CONVERTING-ENZYME; EPIDEMIOLOGIC DATA; PROGNOSTIC-FACTORS; GENE POLYMORPHISM; INCREASED RISK; PROGRESSION; FAILURE; TONSILLECTOMY; ASSOCIATION; INHIBITORS;
D O I
10.1093/ndt/gfp273
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Immunoglobulin A nephropathy (IgAN) is the most common form of glomerulonephritis, and a substantial number of patients succumb to end-stage renal disease (ESRD). However, prediction of the renal outcome in individual patients remains difficult. We have already published a scoring system using the data in a prospective cohort of IgAN patients followed up from 1995 to 2002. Methods. The cohort was further followed up until 2005 in 97 clinical units in Japan. The data from 2283 patients were analysed by Cox regression to determine the predictors of ESRD in IgAN, and their beta-coefficients were converted into scores to estimate ESRD risk within 10 years. Results. During the follow-up (median, 87 months), 252 patients developed ESRD. Male sex, age less than 30 years, family histories of chronic renal failure and chronic glomerulonephritis, hypertension, proteinuria, mild haematuria, hypoalbuminaemia, low glomerular filtration rate and a high histological grade at initial renal biopsy were associated with the risk of ESRD in the multivariable analysis. A scoring system was framed to estimate the 10-year ESRD risk using eight variables significant in both univariable and multivariable models. This prognostic score accurately classified patients by risk: patients with estimates of 0-4.9, 5.0-19.9, 20.0-49.9 and 50.0-100% had an observed incidence of 1.7, 8.3, 36.7 and 85.5%, respectively. The corresponding area under the receiver-operating characteristic curve was 0.942 (95% confidence interval, 0.925-0.958). Conclusion. This validated scoring system to quantitatively estimate ESRD risk during the 10-year follow-up of IgAN patients will serve as a useful prognostic tool in clinical practice.
引用
收藏
页码:3068 / 3074
页数:7
相关论文
共 32 条
[11]  
2-F
[12]   POLYMORPHISMS IN ANGIOTENSIN-CONVERTING-ENZYME GENE AND PROGRESSION OF IGA NEPHROPATHY [J].
HARDEN, PN ;
GEDDES, C ;
ROWE, PA ;
MCILROY, JH ;
BOULTONJONES, M ;
RODGER, RSC ;
JUNOR, BJR ;
BRIGGS, JD ;
CONNELL, JMC ;
JARDINE, AG .
LANCET, 1995, 345 (8964) :1540-1542
[13]   Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy [J].
Hotta, O ;
Miyazaki, M ;
Furuta, T ;
Tomioka, S ;
Chiba, S ;
Horigome, I ;
Abe, K ;
Taguma, Y .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :736-743
[14]   Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy [J].
Hunley, TE ;
Julian, BA ;
Philips, JA ;
Summar, ML ;
Yoshida, H ;
Horn, RG ;
Brown, NJ ;
Fogo, A ;
Ichikawa, I ;
Kon, V .
KIDNEY INTERNATIONAL, 1996, 49 (02) :571-577
[15]   IgA nephropathy:: The presence of familial disease does not confer an increased risk for progression [J].
Izzi, Claudia ;
Ravani, Pietro ;
Torres, Diletta ;
Prati, Elisabetta ;
Viola, Battista Fabio ;
Guerini, Simona ;
Foramitti, Marina ;
Frasca, Giovanni ;
Amoroso, Antonio ;
Ghiggeri, Gian Marco ;
Schena, Francesco Paolo ;
Scolari, Francesco .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (05) :761-769
[16]   Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation [J].
Kanno, Y ;
Okada, H ;
Yamaji, Y ;
Nakazato, Y ;
Suzuki, H .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2005, 98 (03) :199-203
[17]   SIGNIFICANCE OF URINALYSIS FOR SUBSEQUENT KIDNEY AND URINARY-TRACT DISORDERS IN MASS-SCREENING OF ADULTS [J].
KAWAMURA, T ;
OHTA, T ;
OHNO, Y ;
WAKAI, K ;
AOKI, R ;
TAMAKOSHI, A ;
MAEDA, K ;
MIZUNO, Y .
INTERNAL MEDICINE, 1995, 34 (06) :475-480
[18]   MORTALITY PROBABILITY-MODELS (MPM-II) BASED ON AN INTERNATIONAL COHORT OF INTENSIVE-CARE UNIT PATIENTS [J].
LEMESHOW, S ;
TERES, D ;
KLAR, J ;
AVRUNIN, JS ;
GEHLBACH, SH ;
RAPOPORT, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2478-2486
[19]   Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies [J].
Li, LS ;
Liu, ZH .
KIDNEY INTERNATIONAL, 2004, 66 (03) :920-923
[20]   Hong Kong study using valsartan in IgA nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study [J].
Li, Philip Kam-Tao ;
Leung, Chi Bon ;
Chow, Kai Ming ;
Cheng, Yuk Lun ;
Fung, Samuel Ka-Shun ;
Mak, Siu Ka ;
Tang, Anthony Wing-Chung ;
Wong, Teresa Yuk-Hwa ;
Yung, Chun Yu ;
Yung, Jonathan Chee-Unn ;
Yu, Alex Wai-Yin ;
Szeto, Cheuk Chun .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (05) :751-760